https://www.carenet.com/news/general/carenet/63641 CareNet.com ja Registration OpEd 2026-09-22 起きてすぐソーシャルメディアを使う人はうつ病リスクが高い！ medicalnews https://www.carenet.com/news/general/carenet/63623 CareNet.com ja Registration OpEd 2026-09-22 B7-H3標的ADC risvutatug rezetecanが再発小細胞肺がんのOS延長（ARTEMIS-008）／WCLC2026 medicalnews https://www.carenet.com/news/general/carenet/63622 CareNet.com ja Registration OpEd 2026-09-22 医療者で多い心血管リスク因子と管理状況は？／ESC2026 medicalnews https://www.carenet.com/news/general/carenet/63615 CareNet.com ja Registration OpEd 2026-09-22 早期TNBCのMRD検出、tissue-free vs.tumor-informed ctDNAアッセイ／JAMA Oncol medicalnews https://www.carenet.com/news/clear/journal/63611 CareNet.com ja Registration OpEd 2026-09-21 zenagamtide：アミリン受容体がもたらす新たな経口糖尿病治療薬の展望（解説：永井聡氏） medicalnews https://www.carenet.com/news/general/carenet/63646 CareNet.com ja Registration OpEd 2026-09-21 イプタコパンがIgA腎症の適応追加／ノバルティス medicalnews https://www.carenet.com/news/general/carenet/63645 CareNet.com ja Registration OpEd 2026-09-21 T-DXdおよびDato-DXd、転移乳がん患者への1次治療に承認取得／第一三共 medicalnews https://www.carenet.com/news/general/carenet/63640 CareNet.com ja Registration OpEd 2026-09-21 何年禁煙すればアルツハイマー病リスクが元に戻るのか？ medicalnews https://www.carenet.com/news/general/carenet/63634 CareNet.com ja Registration OpEd 2026-09-21 アミバンタマブ皮下注、ラゼルチニブ併用で4週1回投与が可能に／J＆J medicalnews https://www.carenet.com/news/general/carenet/63632 CareNet.com ja Registration OpEd 2026-09-21 再発・難治性濾胞性リンパ腫へのエプコリタマブ、リツキシマブとレナリドミドとの併用療法が承認／ジェンマブ medicalnews https://www.carenet.com/news/general/carenet/63624 CareNet.com ja Registration OpEd 2026-09-21 ペムブロリズマブ、プラチナ抵抗性再発卵巣がんに承認取得／MSD medicalnews https://www.carenet.com/news/general/carenet/63618 CareNet.com ja Registration OpEd 2026-09-21 抗PD-1/VEGF二重特異性抗体ivonescimab、PD-L1陽性進行NSCLCのOS改善（HARMONi-2）／WCLC2026 medicalnews